LKLeonid Yakovlevich Klimov

Leonid Yakovlevich Klimov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leonid Yakovlevich Klimov has a total of 261 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epithelial‑T‑cell axis cytokines and vitamin D status in different asthma phenotypes in children

    by S. V. Dolbnya, V. R. Ponamaryova, I. N. Zakharova, L. Ya. Klimov, A. A. Tolkunova, L. Yu. Barycheva, V. V. Kuznetsova, E. A. Enina, N. A. Fedko, N. V. Zaritovskaya, et al.

    Introduction. Bronchial asthma (BA) is a heterogeneous disease that manifests in various phenotypes; identifying these phenotypes allows for the individualization of treatment, which is particularly important among pediatric patients. Aim . To determine the role of IL-17A and IL-33 in identifying bronchial asthma phenotypes in children receiving prophylactic cholecalciferol. Material and methods . A total of 156 children and adolescents from the Stavropol Krai with asthma, aged 13.5 [10.0; 15.9] years, were studied. During the period 2024–2025, a two-stage study of vitamin D status and IL-17A and IL-33 levels was conducted in children against the background of a 3-month intake of an aqueous solution of cholecalciferol at a dose of 1000 IU/day. Results . We identified three main asthma phenotypes in the study group: atopic asthma – 125 (80.1%), non-atopic asthma – 9 (5.8%), and asthma associated with obesity – 22 (14.1%). Statistically significant differences were found only in parameters determining the patients’ phenotypic classification: total IgE level (p = 0.016) and age-adjusted BMI SDS (p < 0.001). No significant differences in serum calcidiol, IL-17A, and IL-33 levels were observed depending on the phenotype. No significant differences in serum calcidiol, IL-17A, and IL-33 levels were observed across phenotypes; however, there was a trend toward lower vitamin D levels and higher cytokine levels as asthma severity increased. Against the background of a prophylactic course of CC medication, a significant increase in vitamin D sufficiency was observed (p < 0.001), which was accompanied by a decrease in IL-17A levels (p = 0.002). No significant effect on IL-33 levels was detected. Conclusion . A three-month course of prophylactic cholecalciferol supplementation leads to a significant reduction in vitamin D deficiency in children and adolescents with asthma and a decrease in IL-17A levels; when combined with standard stepwise therapy, it improves disease control.

  • Quality of Life in Children and Adolescents with Celiac Disease in the Russian Federation: Results of the Cross-Sectional Multicenter Study

    by A. I. Khavkin, A. A. Lee, I. A. Bavykina, E. A. Balakireva, T. T. Boraeva, А. Kh. Vetrova, S. V. Grechaniy, J. Dolinšek, M. G. Dzgoeva, Yu. A. Dmitrieva, et al.

    Introduction. Assessing the quality of life of patients with various chronic diseases, including celiac disease, is an important component of scientific research, determining the rationale and effectiveness of treatment and rehabilitation strategies. Few studies have examined the quality of life of children with celiac disease on a gluten-free diet. Furthermore, all of these studies utilized a variety of questionnaires. Aim: to study the quality of life of children and adolescents with celiac disease on a gluten-free diet using a validated Russian-language version of the CD-QOL questionnaire. Materials and methods. A cross-sectional study surveyed 599 children and adolescents with celiac disease (aged 2–22 years) using a validated Russian-language version of the CD-QOL questionnaire; the impact of diet on social functioning was also assessed. Comparisons were made using Student’s t -test (Welch’s test was used if homogeneity of variances was not met). For age groups, one-way analysis of variance (ANOVA) was used, with a preliminary check for homogeneity of variances using Levene’s test; in case of homogeneity, Tukey’s post-hoc test was performed. In cases of deviations from normality, the nonparametric Mann — Whitney test was used to compare independent groups. Multiple linear regression was used to assess the influence of factors on indicator levels; associations between variables were additionally assessed using the Pearson or Spearman correlation. The significance level was p < 0.05. Results. The mean subscale scores for 599 respondents were: “social-emotional limitations” — 3.39 (SD = 0.96),“anxiety/fear for health” — 3.16 (SD = 1.07). A moderately strong positive correlation was found between the subscales ( r = 0.649; p < 0.001). No gender differences were found ( p = 0.956 and p = 0.970 for both subscales). In the analysis by age groups, a statistical trend was observed for the “limitations” component (ANOVA: F (3,590) = 2.63; p = 0.053). For the anxiety component, with confirmed homogeneity of variances using Levene’s test, significant between-group differences were revealed (ANOVA: F (3,590) = 8.84; p < 0.001). Tukey’s post-hoc comparisons revealed higher values in younger groups compared to adolescents and adults. Linear regression showed that anxiety was most strongly associated with the severity of socioemotional limitations (β = 0.636; p < 0.001) with an independent negative effect of age (β ≈ –0.24; p < 0.01). The model explained 44.4 % of the variance ( R 2 = 0.444); VIF < 1.1. Psychometric analysis confirmed the two-factor structure with high internal consistency of the subscales (α = 0.904 and α = 0.874). Conclusions. The quality of life of children and adolescents with celiac disease on a gluten-free diet is characterized by moderate "restriction burden" and associated anxiety. Anxiety is higher in younger age groups; no gender differences were found. The priority of medical and social support is to reduce daily limitations through organizational and environmental measures (in educational and leisure contexts, when eating out), supplemented by psychoeducational support for families, especially in younger age groups. According to the study, such measures are associated with reduced anxiety and improved daily functioning.

  • Parental influence on eating behavior in children with celiac disease: a multicenter cross-sectional study

    by A.I. Khavkin, A.A. Lee, I.A. Bavykina, E.A. Balakireva, T.T. Boraeva, A.KH. Vetrova, S.V. Grechanyi, M.G. Dzgoeva, Yu.A. Dmitrieva, R.A. Zhetishev, et al.

    Background. This study examined parental feeding practices and parental perceptions of children’s consumption of “unhealthy” foods under a gluten-free diet (GFD) in celiac disease, as well as approaches to parent–child interaction in the context of reduced quality of life. Materials and Methods. The study was based on a questionnaire survey of parents of children and adolescents with confirmed celiac disease. To ensure reproducibility, the full set of questionnaire items was provided and subscales were constructed to assess parental feeding practices and child behavior, including unhealthy food consumption, emotional feeding, perceived necessity of dietary control, weight-related dietary restriction, encouragement of dietary variety, pressure to eat, child involvement in family meals, and home availability of sweets and snacks. Results. Parental feeding practices demonstrated a multidimensional structure represented by several independent domains. Unhealthy food consumption was common: 78% of parents reported at least partial overconsumption of sweets. Despite strict dietary restrictions, unhealthy snacking remained prevalent. Four distinct parental practice profiles were identified: emotionally controlling, moderately supportive, passive, and weight-restrictive. The perceived necessity of dietary control showed a robust inverse association with unhealthy food consumption, reducing its likelihood by approximately threefold. Conclusion. In children with celiac disease, dietary control represents an adaptive and protective strategy when embedded in everyday family life and implemented through involvement and respect for the child’s autonomy rather than through pressure or punitive measures.

  • Modern Approaches and Results of Comprehensive Assessment of Life Quality in Celiac Disease: Problems and Solutions

    by A. I. Khavkin, J. Dolinšek, E. V. Shrainer, A. V. Nalyotov, T. T. Boraeva, E. A. Yablokova, E. V. Loshkova, L. Ya. Klimov, A. A. Kamalova, K. D. Zavrazhnaya

    Introduction . Celiac disease is a chronic autoimmune disease requiring a lifelong gluten-free diet. Despite the effectiveness of the diet in controlling symptoms, patients’ quality of life remains at risk due to limitations in social, emotional, and gastronomic spheres. Aim : to analyze current approaches to assessing the quality of life of patients with celiac disease in order to optimise strategies for providing care to this category of patients. Key points. Current research emphasizes the importance of not only clinical control, but also of psychosocial support for patients This review describes validated tools for assessing life quality in patients with celiac disease, highlighting the differential impact of the disease on children and adults, the specifics of adherence to and perceptions of a gluten-free diet, and regional and cultural differences in access to support and gluten-free products. An unfavorable psychological state can reduce adherence to a gluten-free diet, creating a vicious cycle. A comparison with other chronic diseases showed that with strict adherence to a gluten-free diet, celiac disease may have a lesser impact on quality of life. Conclusion . Optimizing quality of life requires a multidisciplinary approach — from cultural adaptation of life quality scales to psychological and social support for these patients and normalizing nutrition outside the home.

  • Osteopenic syndrome in type 1 diabetes mellitus

    by R. A. Atanesyan, G. N. Ambartsumyan, L. Y. Klimov, S. V. Dolbnya, G. A. Saneeva

  • Open Access

    Surfactant administration and risk of bronchopulmonary dysplasia in preterm infants

    by N. E. Verisokina, L. Ya. Klimov, A. N. Obedin, O. S. Kirienko, S. V. Dolbnya, V. S. Kaliandra, E. A. Khlopyanova, M. A. Bayramkulov, S. A. Titorenko

    Preterm birth is a major public health concern with an estimated 11% of all live births affected globally. There is a rapid increase in the incidence of preterm births in many industrialized countries in the past decade. Pulmonary surfactant is a phospholipid/ protein complex mixture reducing surface tension at the air-liquid interface in the alveoli. Defective surfactant metabolism can worsen the prognosis for infants born prematurely. Extremely preterm infants appear to have a greater risk of respiratory distress syndrome, leading to a longer duration of mechanical ventilation, which, in turn, increases the risk of bronchopulmonary dysplasia. Bronchopulmonary dysplasia remains the most common adverse outcome of preterm birth. Early exogenous-surfactant administration plays a pivotal role in the management of preterm infants with respiratory distress syndrome, reducing morbidity and mortality. This literature review summarizes current knowledge on the physiological effects of pulmonary surfactant, its composition, and various routes of administration. This systematic review describes the most common method of surface-active agent administration – INSURE, thin catheter techniques, surfactant aerosolization, and surfactant administration via laryngeal or supraglottic airway (SALSA). The literature search was conducted using the following keywords: preterm birth, lasting effects of premature birth, pulmonary surfactant, exogenous surfactant, preterm infants, bronchopulmonary dysplasia. A detailed systematic analysis of current domestic and international literature on surfactant use was conducted. A total of 64 scientific publications were selected for analysis. Databases of eLibrary, Scopus, PubMed, and MEDLINE were used.

  • Open Access

    Social and psychological portrait of a child with celiatic disease and his family: results of a pilot study

    by A. I. Khavkin, A. A. Malakhova, N. D. Odinaeva, I. E. Romanovskaya, E. I. Kondratieva, A. V. Naletov, T. T. Boraeva, O. V. Remizov, E. A. Yablokova, K. D. Zavrazhnaya, et al.

    Introduction. The history of celiac disease research spans more than one millennium, but it is only in the middle of the 20th century that the causal role of gluten was proved. Moreover, the 75 years since then were marked by impressive achievements that enabled an understanding of the nuances of pathogenesis, the development of highly informative diagnostic methods, and the identification of trends in drug treatments for gluten-associated diseases. Given that gluten intolerance and the resulting group of pathological conditions are widespread in the human population as a whole, studies of the quality of life, socio-economic and psychological aspects of the patients’ lives and their immediate environment are of particular value. Purpose of the study. To examine whether children with celiac disease and their immediate environment are satisfied with the availability and quality of social support measures. Materials and methods. This study was based on the results of an online survey conducted among 179 respondents (children, parents and guardians) with an established diagnosis of celiac disease using an original questionnaire to study the satisfaction of celiac patients with the availability and quality of social support measures. Results and discussion. The results of the study suggest that celiac disease in children has a multidimensional impact on the family’s daily life, going beyond clinical issues and affecting a wide range of social, organizational and psychological aspects, representing not only a medical problem, but also a persistent source of social difficulties, which necessitates comprehensive interdisciplinary support. The identified difficulties in confirming the diagnosis and organizing medical support allow us to hypothesize about insufficient integration of patients with celiac disease into primary health care and the lack of medical awareness. That is, children with celiac disease and their families remain in conditions of latent social and medical instability, without receiving a full-fledged, multidisciplinary trajectory of support. At the same time, fragmentary knowledge about social support measures indicates a deficit of institutional information and opacity of mechanisms for inclusion in the care system. This allows us to conclude that celiac disease does not yet hold an important place in the social policy system and remains insufficiently taken into account when forming specialized support measures, and that there is no systemic approach to supporting this group. In addition, the survey results record a persistent impact of the disease on daily activity, including limited mobility, difficulties with organizing meals outside the home, and challenges in academic inclusion. At the same time, against the background of the relatively preserved interpersonal communications and the significant role of support from family members, we can assume the presence of compensatory mechanisms grounded in the resource potential of the immediate social environment. That is, the sustainability of families with a child suffering from celiac disease relies rather on informal resources and internal strategies than on systemic external support. Conclusion. Celiac disease in children is not only a medical problem, but also an indicator of institutional vulnerability, structural gaps in routing, support and information. Effective integration of families into the support system requires a comprehensive interdepartmental model, including: regulatory consolidation of support measures, regular updating and dissemination of information in an accessible form, expansion of gastroenterological services and development of infrastructure for a safe everyday life.


  • Open Access

    A Family case of von Hippel-Lindau syndrome

    by R. A. Atanesyan, L. Y. Klimov, T. M. Vdovina, G. A. Saneeva, E. I. Andreeva, I. K. Gasparian

    Von Hippel-Lindau syndrome (FHL) is a rare autosomal dominant disease that leads to the formation of multiple organ tumor syndrome. The pathology is primarily caused by the inactivation of the VHL gene, which is located on chromosome 3 (3p25/26) and encodes ubiquitin ligase, which destroys hypoxia-induced factor-1α (HIF-1α). The genetic defect leads to the accumulation of HIF-1a protein, activating key carcinogenic pathways, and activated cytokines cause abnormal proliferation of tumor cells and oncogenesis. To date, more than 500 mutations have been registered in VHL. FHL syndrome is characterized by various tumors, including hemangioblastomas of the retina and central nervous system, pheochromocytomas, clear cell renal cell carcinoma, cystic adenoma and others. In the presented clinical description, pheochromocytoma was initially diagnosed in the patient’s mother, and 2 months later in the eldest son. Subsequently, the results of a molecular genetic study made it possible to verify the diagnosis, since in the gene in exon 3 of VHL, a single nucleotide was replaced in the heterozygous state of C.500 G>A, leading to the replacement of the amino acid p.R167Q. Identification of the VHL gene mutation required genetic counseling of all family members, during which a similar mutation was identified in the younger brother. Surgical treatment is the main method of treating FHL syndrome, but advances in genetic research technologies provide new opportunities for the treatment of tumors associated with this syndrome.


  • Open Access

    “Celiac Disease-2025”: Project of Clinical Guidelines for the Diagnosis and Treatment of Celiac Disease in Children

    by Nataliya A. Averkina, Aleksander A. Baranov, Sergey V. Bel’mEr, Tatiyana T. Boraeva, Tatiyana A. Borovik, Tatiyana V. Bushueva, Elena A. Vishneva, Aleksander V. Gorelov, Olga S. Gundobina, Margarita M. Gurova, et al.

    The authors present current data on the etiology, pathogenesis, clinical manifestations of celiac disease in children of different ages, associated diseases, laboratory and instrumental diagnostics, diet therapy, additional treatment methods, vaccination, and follow-up of children with celiac disease based on the developed clinical guidelines “Celiac Disease. Children”.


  • Open Access

    Effectiveness of correction of hypovitaminosis D against the background of standard step therapy of bronchial asthma in children

    by S. V. Dolbnya, V. R. Ponamaryova, I. N. Zakharova, L. Ya. Klimov, A. A. Tolkunova, L. Yu. Barycheva, V. V. Kuznetsova, E. A. Enina, N. N. Zaritovskaya

    Introduction. The close interest of a wide range of pediatricians in the problems of bronchial asthma (BA) is due to its prevalence, difficulties in selecting basic therapy, and the high frequency of hypovitaminosis D.Aim. To analyze the frequency of vitamin D deficiency and the effectiveness of its correction by including cholecalciferol preparations in the standard step therapy regimen for bronchial asthma in children.Materials and methods. The study involved 75 children and adolescents from the Stavropol Territory suffering from BA, aged12.4 [9.5; 14.8] years. From 2018 to 2021, a two-stage study of vitamin D status was conducted in patients – initially and after completion of a 3-month intake of cholecalciferol aqueous solution (CCF).Results. At the 1st stage of treatment, all 3 (100%) patients were over 12 years old and received low doses of ICS each time they used SABA without constant basic therapy. At the 2nd stage of therapy, all 9 (100%) patients used LRA drugs in age-appropriate dosages. At the 3rd stage, 1 (5.3%) child received treatment with medium doses of ICS, 10 (52.6%) children used a fixed combination of ICS-LABA, and 8 (42.1%) a combination of ICS + LRA.The vitamin D status after taking cholecalciferol preparations increased from 18.3 ng/ml to 35.4 ng/ml. Vitamin D deficiency was initially detected in 44 (58.7%) children, and after the correction course – only in 3 (4.0%) people (p < 0.001).Initially, the median AST was 16.0 [12.0; 20.5] points, and at the end of the study 20.0 [16.0; 24.0] points (p < 0.004).Conclusion. Step therapy for asthma should be prescribed in according to current clinical guidelines. ICS should be used more widely as initial basic therapy for asthma, reducing the number of people receiving monotherapy with ALR.